Spots Global Cancer Trial Database for Study of ZIO-101 in Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of ZIO-101 in Multiple Myeloma
Official Title: A Phase I/II Trial of ZIO-101 in Advanced Multiple Myeloma
Study ID: NCT00303199
Conditions
Interventions
Study Description
Brief Summary: The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Little Rock, Arkansas, United States
, West Hollywood, California, United States
, Miami, Florida, United States
, Bethesda, Maryland, United States
, New York, New York, United States
, Cleveland, Ohio, United States
, Edmonton, Alberta, Canada
, Toronto, Ontario, Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
